1. Home
  2. INTS vs BRLT Comparison

INTS vs BRLT Comparison

Compare INTS & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • BRLT
  • Stock Information
  • Founded
  • INTS 2012
  • BRLT 2005
  • Country
  • INTS United States
  • BRLT United States
  • Employees
  • INTS N/A
  • BRLT N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • BRLT Consumer Specialties
  • Sector
  • INTS Health Care
  • BRLT Consumer Discretionary
  • Exchange
  • INTS Nasdaq
  • BRLT Nasdaq
  • Market Cap
  • INTS 33.4M
  • BRLT 22.6M
  • IPO Year
  • INTS 2023
  • BRLT 2021
  • Fundamental
  • Price
  • INTS $2.11
  • BRLT $1.66
  • Analyst Decision
  • INTS Strong Buy
  • BRLT Hold
  • Analyst Count
  • INTS 3
  • BRLT 5
  • Target Price
  • INTS $8.50
  • BRLT $2.40
  • AVG Volume (30 Days)
  • INTS 28.4K
  • BRLT 83.6K
  • Earning Date
  • INTS 03-13-2025
  • BRLT 03-13-2025
  • Dividend Yield
  • INTS N/A
  • BRLT N/A
  • EPS Growth
  • INTS N/A
  • BRLT N/A
  • EPS
  • INTS N/A
  • BRLT 0.03
  • Revenue
  • INTS N/A
  • BRLT $426,982,000.00
  • Revenue This Year
  • INTS N/A
  • BRLT N/A
  • Revenue Next Year
  • INTS N/A
  • BRLT $1.04
  • P/E Ratio
  • INTS N/A
  • BRLT $60.42
  • Revenue Growth
  • INTS N/A
  • BRLT N/A
  • 52 Week Low
  • INTS $1.50
  • BRLT $1.52
  • 52 Week High
  • INTS $5.94
  • BRLT $3.21
  • Technical
  • Relative Strength Index (RSI)
  • INTS 41.98
  • BRLT 42.42
  • Support Level
  • INTS $1.84
  • BRLT $1.58
  • Resistance Level
  • INTS $2.53
  • BRLT $1.75
  • Average True Range (ATR)
  • INTS 0.32
  • BRLT 0.10
  • MACD
  • INTS -0.02
  • BRLT -0.01
  • Stochastic Oscillator
  • INTS 37.50
  • BRLT 22.22

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. Its sales consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.

Share on Social Networks: